The cephalosporins

Mayo Clinic Proceedings

Volumn 74, Issue 2, 1999, Pages 187-195

  Marshall, William F ^a   Blair, Jams E ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFALOTIN; CEFAMANDOLE; CEFAMANDOLE NAFATE; CEFAPIRIN; CEFAZOLIN; CEFDINIR; CEFEPIME; CEFIXIME; CEFONICID; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFPIROME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFRADINE; CEFTAZIDIME; CEFTAZIDIME ARGININE; CEFTIBUTEN; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN; LORACARBEF; UNINDEXED DRUG;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; CONFERENCE PAPER; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG MECHANISM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION;

EID: 0033012813     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/74.2.187     Document Type: Conference Paper

References (25)

1. Cunha BA, Gill MV. Cefepime. Med Clin North Am 1995 Jul;79:721732
2. Sanders CC. Cefepime: the next generation? Clin Infect Dis 1993; 17:369-379
3. Stoeckel K, Hayton WL, Edwards DJ. Clinical pharmacokinetics of oral cephalosporins. Antibiot Chemother 1995;47:34-71
4. Cefpodoxime proxetil-a new oral cephalosporin. Med Lett Drugs Ther 1992:34:107-108
5. Frampton JE, Brogden RN, Langtry HD, Buckley MM. Cefpodoxime proxetil: a review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1992:44:889-917
6. Force RW, Nahata MC. Loracarbef: a new orally administered carbacephem antibiotic. Ann Pharmacother 1993;27:321-329
7. Ceftibuten-a new oral cephalosporin. Med Lett Drugs Ther 1996:38:23-24
8. Jones RN. Cefotaxime and desacetylcefotaxime antimicrobial interactions: the clinical relevance of enhanced activity; a review. Diagn Microbiol Infect Dis 1995; 22:19-33
9. Brogden RN, Spencer CM. Cefotaxime: a reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections. Drugs 1997;53:483-510
10. Norrby SR. Side effects of cephalosporins. Drugs 1987;34(Suppl 2):105-120
11. FeketyFR. Safety of parenteral third-generation cephalosporins. Am J Med 1990;88(Suppl 4A):38S-44S
12. Thompson JW, Jacobs RF. Adverse effects of newer cephalosporins: an update. Drug Saf 1993:9:132-142
13. Schichor A, Bernstein B, Weinerman H, Fitzgerald J, Yordan E, Schechter N. Lidocaine as a diluent for ceftriaxone in the treatment of gonorrhea: does it reduce the pain of the injection? [published erratum appears in Arch Pediatr Adolesc Med 1995;149:271]. Arch Pediatr Adolesc Med 1994;148:72-75
14. Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995;74:167-170
15. Goddard JK, Janning SW, Gass JS, Wilson RF. Cefuroxime-induced acute renal failure. Pharmacotherapy 1994;14:488-491
16. Park HZ, Lee SP, Schy AL. Ceftriaxone-associated gallbladder sludge: identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology 1991;100:1665-1670
17. Creel GB, Hurtt M. Cephalosporin-induced recurrent aseptic meningitis. Ann Neurol 1995;37:815-817
18. James PA, Reeves DS. Bacterial resistance to cephalosporins as a function of outer membrane permeability and access to their target. J Chemother 1996;8(Suppl 2):37-47
19. Sanders WE Jr, Tenney JH, Kessler RE. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. Clin Infect Dis 1996:23:454-461
20. Livermore DM, Yuan M. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. JAntimicrob Chemother 1996;38:409424
21. The choice of antibacterial drugs. Med Lett Drugs Ther 1996;38:2534
22. Thorpe EM, Schwebke JR, Hook EW III, Rompalo A, McCormack WM, Mussari KL, et al. Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains. Antimicrob Agents Chemother 1996;40:27752780
23. Francioli P, Etienne J, Hoigne R, Thys JP, Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks: efficacy and outpatient treatment feasibility. JAMA 1992;267:264-267
24. Francioli PB. Ceftriaxone and outpatient treatment of infective endocarditis. Infect Dis Clin North Am 1993 Mar;7:97-115
25. Wilson WR. The role of fourth-generation cephalosporins in the treatment of serious infectious diseases in hospitalized patients. Diagn Microbiol Infect Dis 1998;31:473-477